Arkolith/Insider Trading/GRTX/Form 4

Holmlund Jon T

Chief Medical OfficerGalera Therapeutics, Inc. (GRTX) · full profile →Form 4 · filed Sep 3, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$404K
Net Open-Market Flow
-$404K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2021Sell(S)48K$8.47$404K0
Sep 1, 2021Option exercise(M)48K$2.43$116K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2021Option exercise(M)48K—$061K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-035130) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML